Media Summary: Rick Schneider and Maxime Allard , co-founders of Stephen MacKinnon is the VP of Applied ML at Recursion Pharmaceuticals, a next-generation biopharmaceutical company that is ... Gabriele Corso, CEO and co-founder of Boltz, believes the most powerful AI

Inside Helical Bio Foundation Models - Detailed Analysis & Overview

Rick Schneider and Maxime Allard , co-founders of Stephen MacKinnon is the VP of Applied ML at Recursion Pharmaceuticals, a next-generation biopharmaceutical company that is ... Gabriele Corso, CEO and co-founder of Boltz, believes the most powerful AI Staff Research Scientist at InstaDeep, Thomas Pierrot, delves into pioneering foundational Vector Institute's Remarkable 2024 Brendan Frey - BigRNA: A Passionate about medicine and engineering, Maxime Allard, Mathieu Klop and Rick Schneider have combined the two fields by ...

In our season six finale, we dive deeper into how artificial intelligence (AI) is shaping the future of drug discovery and scientific ... Join the Slack to connect with the speakers: ...

Photo Gallery

Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery
Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery
Helical: Bio foundation models at the fingertips of scientists
LuxProvide x Helical Exclusive Interview | Revolutionizing BioTech with AI & Supercomputing
Foundation Models in Drug Discovery: Recursion VP of AI Stephen MacKinnon | Ray Summit 2024
Democratizing AI for Biology | Discovery Engines
10 Years of AI: Building foundation models to transform biology
Why AI Needs Biology to Transform Medicine
Brendan Frey - BigRNA: A Foundation Model of RNA Biology That Unlocks Drug Discovery | Remarkable 24
From LLMs to Multi-Agent AI Systems in Drug Discovery - Inside Bio-IT World
Helical founders: How AI can accelerate drug development
S6E07: Foundation Models and Agents
View Detailed Profile
Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery

Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery

Tech and Drugs – Episode #11

Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery

Inside Helical: Bio Foundation Models, Virtual Cells, and the Future of AI-Native Drug Discovery

Tech and Drugs – Episode #11

Helical: Bio foundation models at the fingertips of scientists

Helical: Bio foundation models at the fingertips of scientists

Rick Schneider and Maxime Allard , co-founders of

LuxProvide x Helical Exclusive Interview | Revolutionizing BioTech with AI & Supercomputing

LuxProvide x Helical Exclusive Interview | Revolutionizing BioTech with AI & Supercomputing

LuxProvide and

Foundation Models in Drug Discovery: Recursion VP of AI Stephen MacKinnon | Ray Summit 2024

Foundation Models in Drug Discovery: Recursion VP of AI Stephen MacKinnon | Ray Summit 2024

Stephen MacKinnon is the VP of Applied ML at Recursion Pharmaceuticals, a next-generation biopharmaceutical company that is ...

Democratizing AI for Biology | Discovery Engines

Democratizing AI for Biology | Discovery Engines

Gabriele Corso, CEO and co-founder of Boltz, believes the most powerful AI

10 Years of AI: Building foundation models to transform biology

10 Years of AI: Building foundation models to transform biology

Staff Research Scientist at InstaDeep, Thomas Pierrot, delves into pioneering foundational

Why AI Needs Biology to Transform Medicine

Why AI Needs Biology to Transform Medicine

A deep conversation on how

Brendan Frey - BigRNA: A Foundation Model of RNA Biology That Unlocks Drug Discovery | Remarkable 24

Brendan Frey - BigRNA: A Foundation Model of RNA Biology That Unlocks Drug Discovery | Remarkable 24

Vector Institute's Remarkable 2024 | Brendan Frey - BigRNA: A

From LLMs to Multi-Agent AI Systems in Drug Discovery - Inside Bio-IT World

From LLMs to Multi-Agent AI Systems in Drug Discovery - Inside Bio-IT World

In Episode 4 of

Helical founders: How AI can accelerate drug development

Helical founders: How AI can accelerate drug development

Passionate about medicine and engineering, Maxime Allard, Mathieu Klop and Rick Schneider have combined the two fields by ...

S6E07: Foundation Models and Agents

S6E07: Foundation Models and Agents

In our season six finale, we dive deeper into how artificial intelligence (AI) is shaping the future of drug discovery and scientific ...

On the Future of AI for Drug Discovery | Yoshua Bengio, Marinka Zitnik, Djork-Arné Clevert

On the Future of AI for Drug Discovery | Yoshua Bengio, Marinka Zitnik, Djork-Arné Clevert

Join the Slack to connect with the speakers: ...